Are Our Patients Better Off With Drug-Eluting Stents in Saphenous Vein Grafts?

JACC: Cardiovascular Interventions

Volumn 2, Issue 11, 2009, Pages 1113-1115

  Douglas Jr , John S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery grafts; saphenous vein grafts; stents

Indexed keywords

BARE METAL STENT; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEATH; DRUG ELUTING STENT; EDITORIAL; GRAFT FAILURE; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REOPERATION; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449490390     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.09.007     Document Type: Editorial

References (12)

1. Gruentzig A.R., Senning A., and Siegenthaler W.E. Nonoperative dilatation of coronary artery stenosis. Percutaneous transluminal coronary angioplasty. N Engl J Med 301 (1979) 61-68
2. Douglas J.S., Gruentzig A.R., King S.B., et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol 2 (1983) 745-754
3. Savage M.P., Douglas Jr. J.S., Fischman D.L., et al. Stent placement compared with balloon angioplasty for obstructed bypass grafts. Saphenous vein De Novo Trial Investigators. N Engl J Med 337 (1997) 740-747
4. Brodie B.R., Wilson H., Stuckey T., et al., STENT Group. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) Group. J Am Coll Cardiol Intv 2 (2009) 1105-1112
5. Vermeersch P., Agostoni P., Verheye S., et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in decreased saphenous vein grafts. J Am Coll Cardiol 48 (2006) 2423-2431
6. Vermeersch P., Agostoni P., Verheye S., et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts. J Am Coll Cardiol 50 (2007) 261-267
7. Applegate R.J., Sacrinty M., Kutcher M., et al. Late outcomes of drug-eluting versus bare-metal stents in saphenous vein grafts: propensity score analysis. Catheter Cardiovasc Interv 72 (2008) 7-12
8. Brilakis E.S., Lichtenwalter C., de Lemos J.A., et al. A randomized-controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions: the SOS (Stenting Of Saphenous vein grafts). J Am Coll Cardiol 53 (2009) 919-928
9. Rodes-Cabau J., Facta A., Larose E., et al. Predictors of aorto-coronary saphenous vein bypass narrowing late after coronary artery bypass grafting. Am J Cardiol 100 (2007) 640-645
10. Ellis S.G., Brener S.J., DeLuca S., et al. Late myocardial ischemic events after saphenous vein graft intervention: importance of initially "non-significant" vein graft lesions. Am J Cardiol 79 (1997) 1460-1464
11. Rodes-Cabau J, Bertrand OF, Larose E, et al. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy in the treatment of non-significant saphenous vein graft lesions. Paper presented at: Late Breaking Trial Presentation of the 58th Scientific Sessions of the American College of Cardiology; March 28-31, 2009; Orlando, FL.
12. Blankenship J.C. Parsing the subsets: when small studies create confusion. Cathet Cardiovasc Interv 72 (2008) 23-24